Genetic Factors and the Outcomes of Transplant-Associated Thrombotic Microangiopathies
Nie, D.; Liu, L.
Show abstract
Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe endothelial complication following allogeneic hematopoietic stem-cell transplantation (allo-HSCT), associated with high mortality when not promptly diagnosed and treated. This study aimed to delineate the genetic landscape associated with TA-TMA and assess its impact on clinical outcomes. We retrospectively analyzed 1069 allo-HSCT recipients between January 2016 and May 2020, identifying 131 patients who met diagnostic criteria for TA-TMA (incidence rate: 12.25%). Genomic DNA sequencing was performed targeting 17 complement- related genes, identifying 74 genetic variants in 58 TA-TMA patients, including seven large deletions within the CFH-CFHR5 locus. Survival analysis indicated significantly poorer outcomes for TA-TMA patients compared to non-TMA patients (24.4% vs 62.4% survival at maximum follow-up, p = 0.025). However, cumulative incidence curves revealed no significant difference in TA-TMA onset between genetic variant carriers and non-carriers. These findings underscore the complexity of TA-TMA pathogenesis, suggesting that genetic predisposition alone is insufficient without additional endothelial insults. The limited predictive value of individual markers highlights the need for integrated biomarker strategies. Future research should focus on refining risk stratification models incorporating comprehensive genetic profiles, dynamic biomarkers, and longitudinal clinical parameters to enable earlier identification and targeted interventions, thereby improving post-transplant survival outcomes.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia 93%
- Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia 92%
- Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT 92%
Similar papers in this journal
- Sickle red blood cell derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor 92%
- Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents 91%
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 90%
Similar papers in this journal
- Mitigation of gastrointestinal graft versus host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination 94%
- Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations 92%
- Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia 91%
Similar papers in this journal
- Perturbations of the T-cell immune repertoire in kidney transplant rejection 95%
- Dental biofilm microbiota dysbiosis is associated with the risk of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 94%
- Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients 93%
Similar papers in this journal
- Donor Bone Marrow Derived Macrophage Engraftment into the Central Nervous System of Allogeneic Transplant Patients 93%
- Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma 92%
- Using Whole Genome Sequencing to Characterize Clinically Significant Blood Groups Among Healthy Older Australians 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.